Country: Tanzania
Language: English
Source: Tanzania Medicinces & Medical Devices Authority
Zinc Sulfate Monohydrate
IPCA Laboratories Limited, INDIA
Other mineral supplements
Zinc Sulfate Monohydrate
20
Tablet, Dispersible
IPCA LABORATORIES LIMITED , INDIA
Physical description: White to off white, round, flat faced bevel edge, uncoated dispersible tablets with break line on one side and debossed with ‘C 70’ on other side; Local technical representative: Phillips Distributors Limited (9823)
Registered/Compliant
2021-11-26
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Ozin c-DT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each uncoated dispersible tablet contains: Zinc sulfate monohydrate USP (54.9 mg) equivalent to elemental zinc…….20 mg Excipient with known effect: Each uncoated dispersible tablet contains 46.43 mg of Aspartame. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM White to off white, round, flat faced bevel edge, uncoated dispersible tablets with break line on one side and debossed with ‘C 70’ on other side. The tablet can be divided into equal halves. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ozinc-DT is indicated for the treatment of acute and persistent diarrhoea in infants and children up to 5 years of age. _This product is intended for use in children. Nonetheless, safety information is _ _provided with respect to adult health issues such as liver disease, pregnancy _ _and lactation, to allow full access to all relevant information._ 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _For _ _acute _ _and _ _persistent _ _diarrhoea_ For children less than 6 months of age: ½ tablet once daily for 10-14 days. For children 6 months of age to 5 years of age: 1 tablet once daily for 10-14 days. The tablet (or half tablet) should be dispersed completely in 1 teaspoon (5 ml) of clean water or breast milk and the entire amount administered orally to the infant or child. It is recommended that doses be administered between meals and a repeat dose be given if vomiting occurs within 30 minutes. For missed doses, the missing dose can be taken as soon as possible, unless there is less than 6 hours until the next dose. 4.3 CONTRAINDICATIONS The product is contraindicated in case of hypersensitivity to the active substance or any of the excipients listed in section 6.1. as well as in Copper deficiency. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Accumulation of zinc may occur in cases of renal failure. Drugs which may inhibit zinc absorption, such as penicillamine, sodium va Read the complete document